Signal · Regulation & Trade
Target Animal Safety Evaluation for Veterinary Monoclonal Antibody Products; Draft Guidance for Industry; Availability
What the source reported
Source-reportedThe Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry (GFI) #298 (VICH GL62) titled "Target Animal Safety Evaluation for Veterinary Monoclonal Antibody Products." This draft guidance has been developed for veterinary use by the International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products (VICH). This draft guidance contributes to the international harmonization of methods used for the target animal safety (TAS) evaluation of veterinary monoclonal antibody products (VMAPs) and aids in preparing and conducting VMAP TAS studies under laboratory and field conditions. A harmonized standard is intended to aid in development of mutually acceptable VMAP TAS programs.
- Publication
- US Federal Register - FDA (food, drug, device rules) · Government/Regulator
- Published
- 18th September 2026
- Original report
- federalregister.gov
ProcIntel stores what the source published in its feed — a headline, a summary and a link. It does not store or reproduce the full article.
What ProcIntel recorded
ProcIntel-derived- Category
- Regulation & Trade
- Geography
- United States
- Organisations
- None identified
- Collected
- 28th September 2026 · 16:31
Initial assessment ProcIntel's automatic, provisional read of this individual Signal -- Initial Significance and Initial Confidence, computed deterministically before any Event extraction or human review.
A provisional, automatically computed reading of this individual Signal, before Event extraction or human review. Not a final rating.
Initial Significance Low (11.0/100). Strongest contributor: Procurement Impact (6.0/30 points). Limiting factor: Geographic Breadth (0.0/10 points). Initial Confidence Low (39/100, data sufficiency: Insufficient). Strongest contributor: Source Authority (40.0/40 points). Limiting factor: Specificity (0.0/20 points). Capped at 39 (Low) -- insufficient structured evidence to support a higher Confidence reading, regardless of source authority.
- Strongest contributor
- Procurement Impact
- Limiting factor
- Geographic Breadth